Amulet and Watchman Equal for Still left Atrial Appendage Closure

Amulet and Watchman Equal for Still left Atrial Appendage Closure

SAN FRANCISCO — 13 months soon after percutaneous remaining atrial appendage closure (LAAC), outcomes did not differ whether closure was done utilizing the Amulet (Abbott Cardiovascular) or the Watchman FLX (Boston Scientific) products.  The SWISS-APERO trial randomly assigned individuals undergoing clinically indicated LAAC whose LAA anatomy was considered acceptable to receive both product. …
Read More

You May Also Like